Lyka Labs Ltd.

124.00 -0.05 ▼0.0%

27 February 2024, 02:30:57 PM
Volume: 32,004

Company Profile

Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.lykalabs.com
Market Cap 410.65 Cr.
Enterprise Value(EV) 462.04 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) -1.08 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2023-12
Industry PE 41.67 Trailing Twelve Months Ending 2023-12
Book Value / Share 21.22 Trailing Twelve Months Ending 2023-12
Price to Book Value 5.85 Calculated using Price: 124.10
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 3.31 Cr. 33,090,000 Shares
FaceValue 10
About Lyka Labs Ltd.
Lyka Labs Ltd was incorporated on December 29, 1976 as a private limited company and converted into a public limited company on December 19, 1985.

Lyka Labs Ltd. Delivery

Delivered Qty
Traded Qty

Lyka Labs Ltd. Performance

1 Day
-0.04%
1 Week
-6.70%
1 Month
+1.27%
3 Month
-11.87%
6 Month
+1.97%
1 Year
+4.55%
2 Year
-9.36%
5 Year
+452.34%
10 Year
+1191.67%

Lyka Labs Ltd. Fundamental Ratios

9 years 2015-06 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) -13.05 11.74 -18.27 -46.3 -14.2 -448.65 0 0 -63.63
Return on Capital Employed (%) 11.73 12.41 6.66 -6.52 -5.5 -31.39 8.95 56.68 -1
Return on Assets (%) -1.55 1.58 -2.7 -8.02 -2.97 -32.05 -5.58 21.4 -7.8

Lyka Labs Ltd. Balance Sheet

Particulars 10 years 2015-06 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 43 45 38 49 43 -14 -26 13 45 68
Non Curr. Liab. 37 29 39 5 72 137 149 73 73 53
Curr. Liab. 195 163 165 167 85 66 50 99 33 30
Minority Int. 4 4 7 3 3 -1 1 0 0 0
Equity & Liab. 279 241 249 225 203 188 174 186 152 152
Non Curr. Assets 177 159 186 176 168 152 145 133 107 105
Curr. Assets 102 82 63 49 35 36 29 52 44 47
Misc. Exp. not W/O
Total Assets 279 241 249 225 203 188 174 186 152 152

Lyka Labs Ltd. Profit and Loss

Particulars 10 years 2015-06 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 166 130 110 60 71 61 86 194 93 106
Other Income 2 2 2 2 2 3 2 2 3 2
Total Income 169 132 112 62 73 65 88 196 96 107
Total Expenditure -138 -110 -87 -63 -73 -65 -67 -93 -76 -89
PBIDT 31 22 25 -1 0 -1 21 103 20 19
Interest -26 -16 -19 -10 -7 -20 -26 -20 -12 -7
Depreciation -11 -9 -10 -11 -7 -8 -8 -17 -14 -13
Taxation -1 0 2 1 9 -1 4 -21 0 -1
Exceptional Items 2 7 -4 2 -1 -33 -1 -7 -7 -1
PAT -5 4 -7 -19 -6 -63 -10 38 -13 -4
Minority Interest 0 0 1 2 1 2 -1 1 0 0
Share Associate
Other Related Items
Consolidated Net Profit -5 4 -6 -17 -6 -61 -12 39 -13 -4
Adjusted EPS -2 2 -3 -6 -2 -21 -4 14 -4 -1

Lyka Labs Ltd. Cash Flow

Particulars 10 years 2014-06 Rs. Cr. 2015-06 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 89 27 12 31 11 27 5 9 79 9
Cash Fr. Inv. -57 29 17 -13 -3 -4 0 0 -6 7
Cash Fr. Finan. -26 -60 -30 -19 -10 -23 3 -12 -63 -22
Net Change 6 -4 -1 0 -3 -1 9 -3 10 -5
Cash & Cash Eqvt 11 7 6 5 2 2 10 7 17 12

Lyka Labs Ltd. Shareholding Pattern

9 Qtrs 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%)
Promoter 20.04 47.79 47.80 47.59 47.59 51.00 54.58 54.81 54.81
Public 79.96 52.21 52.20 52.41 52.41 49.00 45.42 45.19 45.19
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 16.98 7.12 5.53 5.12 5.12 0.00 0.00 0.00 0.00

Lyka Labs Ltd. Announcements

Fri, 23 Feb 2024
Shareholders meeting
Submission of Voting Results of the Postal Ballot along with Scrutinizer's Report
Wed, 21 Feb 2024
Shareholders meeting
Voting results of the meeting of the Preference Shareholder of the Company conveyed on Tuesday, 20th February 2024, as per the NCLT Order.
Wed, 21 Feb 2024
Shareholders meeting
Voting results of the meeting of the unsecured creditors of the Company conveyed on Tuesday, 20th February 2024, as per the NCLT Order.

Lyka Labs Ltd. Technical Scans

Mon, 26 Feb 2024
Making Lower Lows for 3 days Making Lower Lows for 3 days
Close Within 52 Week High Zone Close Within 52 Week High Zone
Making Lower Lows for 2 Days Making Lower Lows for 2 Days
High Decrease in 3 Months High Decrease in 3 Months
High Increase in 5 Years High Increase in 5 Years

Lyka Labs Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 373,564.46 1,574.60 +1.1%
Cipla Ltd. 118,662.53 1,482.20 +0.8%
Dr. Reddy's Laboratories Ltd. 107,402.65 6,416.00 -0.4%
Zydus Lifesciences Ltd. 95,410.36 939.50 -0.3%
Divi's Laboratories Ltd. 94,984.66 3,521.95 -1.6%
Apollo Hospitals Enterprise Ltd. 94,585.14 6,606.15 +0.3%
Torrent Pharmaceuticals Ltd. 88,769.16 2,612.40 -0.4%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 41.94 1,574.60 +1.1%
Cipla Ltd. Consolidated 2023-12 32.00 1,482.20 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 20.54 6,416.00 -0.4%
Zydus Lifesciences Ltd. Consolidated 2023-12 32.08 939.50 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-12 68.68 3,521.95 -1.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 119.83 6,606.15 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 59.42 2,612.40 -0.4%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 5.99 1,574.60 +1.1%
Cipla Ltd. Consolidated 2023-12 4.58 1,482.20 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 4.00 6,416.00 -0.4%
Zydus Lifesciences Ltd. Consolidated 2023-12 4.91 939.50 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-12 7.29 3,521.95 -1.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 14.00 6,606.15 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 12.41 2,612.40 -0.4%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,574.60 +1.1%
Cipla Ltd. Consolidated 2023-03 0.02 1,482.20 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,416.00 -0.4%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 939.50 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,521.95 -1.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,606.15 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,612.40 -0.4%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,574.60 +1.1%
Cipla Ltd. Consolidated 2023-03 12.85 1,482.20 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,416.00 -0.4%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 939.50 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,521.95 -1.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,606.15 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,612.40 -0.4%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,574.60 +1.1%
Cipla Ltd. Consolidated 2023-03 12.85 1,482.20 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,416.00 -0.4%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 939.50 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,521.95 -1.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,606.15 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,612.40 -0.4%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,574.60 +1.1%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,482.20 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,416.00 -0.4%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 939.50 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,521.95 -1.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,606.15 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,612.40 -0.4%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,574.60 +1.1%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,482.20 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,416.00 -0.4%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 939.50 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,521.95 -1.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,606.15 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,612.40 -0.4%

Lyka Labs Ltd. FAQ's

What is Lyka Labs share price?

Can I buy Lyka Labs shares now?

What is the Market Cap of Lyka Labs?

What are the key metrics to analyse Lyka Labs?

What is the 52 Week High and Low of Lyka Labs?

What is the trend of Lyka Labs share price?